Nanode Therapeutics, Inc

Rhodes Technologies is an independently operated company that manufactures a range of active ingredients for the pharmaceutical industry. Its chemical reaction capabilities include acetylenic and chiral chemistry, aldol condensation, cryogenic and liquid ammonia reactions, hydrogenization, optical resolution, hydride reduction and sulfoxidation. The company s production equipment includes micronization suites with jet mills, centrifuges, automated titus reactors, and drying and distillation systems. Rhodes Technologies operates research and development and quality control laboratories that specialize in product development. It also organizes a variety of meetings, expositions and trade shows. Rhodes Technologies is located in Coventry, R.I.

Tedor Pharma Inc is a US-based contract development and manufacturing organization (CDMO) specializing in the reliable manufacture of high-quality solid dose pharmaceuticals and controlled substances. With over 20 years of experience, their comprehensive and flexible services, from formulation development to commercial manufacturing, ensure speed, quality, and efficiency in delivering pharmaceutical products to patients. Located in Cumberland, RI, just an hour south of Boston, MA, Tedor Pharma's state-of-the-art facility is FDA registered and inspected, and DEA licensed to manufacture controlled substances. Their expert staff provides end-to-end outsourcing solutions, including clinical trial services, analytical services, and GMP manufacturing, making them a trusted partner for small molecule drug product development.Generated from the website

VeraMorph LLC, located in Mansfield, MA, is dedicated to prolonging and enhancing the quality of life for patients through innovative therapeutic solutions. The company is driven by a team of seasoned entrepreneurs and executives with expertise in drug delivery and product design, focused on developing therapies that maximize efficacy. Utilizing a proprietary oral drug delivery platform, VeraMorph aims to assist companies in the clinical translation of poorly soluble compounds while cultivating a portfolio of specialty drug products. Their commitment to creating clinically-differentiated oral versions of approved drugs positions them at the forefront of advancing therapeutic options. Generated from the website